Segall Bryant & Hamill LLC Invests $4.48 Million in Ardent Health Partners, LLC (NYSE:ARDT)

Segall Bryant & Hamill LLC purchased a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 262,207 shares of the company’s stock, valued at approximately $4,478,000. Segall Bryant & Hamill LLC owned 0.18% of Ardent Health Partners at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Wellington Management Group LLP purchased a new position in shares of Ardent Health Partners during the third quarter valued at approximately $28,724,000. Point72 Asset Management L.P. bought a new position in Ardent Health Partners during the 3rd quarter valued at approximately $27,428,000. Goldentree Asset Management LP purchased a new position in Ardent Health Partners during the third quarter valued at $22,897,000. Franklin Resources Inc. bought a new stake in Ardent Health Partners in the third quarter worth $15,839,000. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of Ardent Health Partners by 9.2% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 779,601 shares of the company’s stock worth $13,136,000 after acquiring an additional 65,833 shares during the last quarter.

Ardent Health Partners Stock Up 0.3 %

ARDT stock opened at $13.15 on Friday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners, LLC has a 1 year low of $12.87 and a 1 year high of $20.72. The stock’s fifty day moving average price is $14.43 and its 200-day moving average price is $16.28.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. Equities analysts anticipate that Ardent Health Partners, LLC will post 1.23 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ARDT shares. Stephens reaffirmed an “overweight” rating and issued a $22.00 price target on shares of Ardent Health Partners in a research report on Wednesday. Morgan Stanley dropped their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Truist Financial reduced their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Royal Bank of Canada cut their target price on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 4th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Ardent Health Partners presently has a consensus rating of “Buy” and an average price target of $21.18.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.